Strategic Partnerships AP-HP engages in active international collaboration with universities and research institutes (Cairo University, Theodor Bilharz Research Institute, Université Paris Cité, Beaujon Hospital) and private partners (One Biosciences, Owkin, Pixyl) across AI, gene therapy, and kidney disease research, indicating sales opportunities in collaboration tools, AI for diagnostics, and shared research platforms.

Digital Health Innovation The hospital’s involvement in AI for oncology through Owkin, digital health challenges via The Bernoulli Lab with Inria, and AI-powered imaging solutions (Pixyl) suggests a strong openness to advanced software, data platforms, and analytics services that can enhance clinical decision support and research workflows.

Research-Driven Growth With hundreds of research projects, thousands of publications, and a large network of rare disease reference centers, there is clear demand for high-capacity data management, research collaboration tools, and translational science platforms to accelerate findings into clinical practice.

Multi-Site Scalability As a major pediatric hospital group with extensive specialty services and 50 rare disease centers, AP-HP represents a buyer for scalable IT infrastructures, cloud-based clinical data platforms, and secure inter-hospital data sharing capabilities to support nationwide collaboration.

Global Collaboration Demand Recent partnerships with international institutions and consortia signal a need for global data interoperability, regulatory-compliant cloud solutions, and international project management tools to coordinate cross-border research and clinical initiatives.